Clinical Trial Update: Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating rosiglitazone for efficacy and safety in Alzheimer's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-11-18